A study was recently published which claimed that there is a lack of association between cardiovascular disease (CVD) and total cholesterol; the authors even went on to claim that higher levels of cholesterol may prolong life and suggest that lowering cholesterol via medication is useless. This view is not only extreme, but also garnering a lot of criticism. Statins are commonly prescribed to mitigate symptoms associated with many different disorders, such as hypertension, diabetes and peripheral artery disease (PAD). For now, the jury is out on whether or not the study carries any weight, as a substantial amount of evidence will need to be collected before physicians give up on statins.

“Personalized medicine” is an increasingly popular catchphrase in modern health care and advocates of this approach argue that doctors should not assume that one treatment will work for every patient with a certain disease or condition. Instead, it’s believed that doctors should prescribe individualized medical treatments based on an evaluation […]

Over the past few years, the medical community’s approach to healthcare has changed. If you’ve visited your primary care physician within the last year or two, no doubt you’ve experienced firsthand the increased emphasis on preventative medicine. Some advice you might have received likely included exercise more, lose weight and watch your diet. With obesity rates in the United States skyrocketing, this renewed focus isn’t surprising—especially in light of the fact that obesity is linked to chronic conditions such as cardiovascular disease and metabolic disorders. One of these chronic diseases is type-2 diabetes, which is initially treated with a regimen similar to the one used to prevent obesity. Due to the connection between the two conditions, the overlap makes sense. In fact, preventing obesity is considered the first step to lowering your chances of developing type-2 diabetes. Like obesity, weight management through diet and exercise isn’t always an effective form of type-2 diabetes treatment. When these methods fail, patients often then turn to other therapies such as medication or insulin shots to control glucose levels. But with the price of insulin rising, there has been an increased interest in finding alternative type-2 diabetes treatment options.

At medical schools and research facilities across the country, physicians and scientists are trying to discover ways to ensure that treatments are more specific and targeted than ever before. Gone are the days when experts are content with a “one-drug-fits-all” style pharmacology. In cancer therapy, these experts are turning to antibody-drug conjugates to serve their needs for specificity in the hope that these therapies will eliminate the often terrible side effects of chemotherapy and result in long-lasting relief from cancer.